Skip to main content
. 2020 Nov 23;39:251. doi: 10.1186/s13046-020-01774-w

Fig. 6.

Fig. 6

WNT4 promote angiogenesis in colorectal cancer. a and b The expression of CD31 (red) in different groups: LoVo-Scramble or LoVo-shWNT4 (a), SW480-WNT4-vector or SW480-WNT4-HA. Scale bar, 50 μm. c The ability of tube formation was significantly improved when HUVECs were treated with conditioned media (CM) from SW480 cells transfected with WNT4-HA than that from SW480 transfected WNT4-vector, and it could be blocked by the β-catenin/TCF inhibitor ICG-001 (10 μM). Scale bar, 100 μm. d TOP/FOP-Flash reporter was used to detect whether the WNT pathway was activated. e and f The levels of ANG2 were detected by RT-qPCR and ELISA in HUVECs that underwent different treatments. g and h The mRNA level of ANG2 in cells and CM of HUVECs transfected with negative control shRNA (Scramble) and sh-ANG2 were detected by RT-qPCR. i The ability of tube formation promoted by high WNT4 expression was significantly inhibited due to low ANG2 expression. Scale bar, 100 μm. **P < 0.01